GEN - Genetic Engineering and Biotechnology News

Drug Discovery Innovation: Target Deconvolution and Tractability Assessment

In this GEN webinar, our expert speakers will explore cutting-edge drug discovery techniques for target deconvolution and multiplex target discovery.
BioSpace

Bridging Formulation and Device: Integrated Supply Chain Strategies for U.S. Pharma Manufacturing

The pharmaceutical supply chain and device development have become intricately linked. Harmonizing formulation development ...
BioSpace

Accelerating timelines and reducing cost in early clinical drug development with ICON’s Accelerated Pharmaceutical Solutions

Innovation drives speed in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions integrate advanced ...
Fierce Biotech

How AI and real-world evidence are powering smarter decisions across the drug and device development lifecycle

Pharma and biotech companies have access to an unprecedented variety of health data, from electronic health records and ...

Common aldehydes transformed by light could accelerate drug discovery and material development

A new chemical method that could speed up the creation of medicines, materials and products people rely on every day has been ...

OncoPrecision Announces Oral Presentation of ONC001, a First-in-Class CD64-Targeting ADC for Monocytic Leukemia, at the 67th ASH Annual Meeting

ONC001 is a first-in-class antibody-drug conjugate (ADC) designed to uniquely target CD64, a myeloid-restricted receptor pervasively expressed in CMML and M4/M5 acute myeloid leukemia, including ...
IPWatchdog

Inventing Miracles: How Patent Policy Shapes Drug Development

In our latest IPWatchdog Unleashed podcast, I spoke with Rob Sahr, shareholder at Wolf Greenfield and co-chair of our 2025 Life Sciences Masters™ program. Our conversation zeroed in on a hard truth ...